Beryl Drugs Ltd's earnings have declined by -9.7%, whereas share price has declined -8% CAGR over the past five years, indicating the company’s share price is likely overvalued. However, for specific investment actions please consult your investment advisor.
Beryl Drugs Ltd share price has declined -4.3% annually (CAGR) over the past ten years.
Data is not available for this company.
Beryl Drugs incorporated in 1993 is into manufacturing and marketing of branded, generic pharmaceutical formulations. The company is one of leading manufacturer of I.V.fluids and small volume injectables.
Beryl has emerged into a global network of pharmaceutical manufacturing, research and development, contract manufacturing services and veterinary products.
The manufacturing facilities of the company are in compliance with WHO GMP specifications.
Company owns brands like
Company owns brands like BERI-CEF injection, F-Neuron, Amplicillin INJ, P-Mol, Biprox, B-Flox and many more.
The shares of Beryl Drugs are listed on M.P. Stock Exchange, Bombay Stock Exchange and Ahmedabad Stock Exchange.
Products manufactured by the company:
The company has received ISO 9001:2000 certification for its quality management.